Johannes Schmidt – författare
1 926 kr
Skickas inom 10-15 vardagar
Today, the pressure on healthcare costs and resources is increasing, and especially for biopharmaceuticals that require parenteral administration, the inherent complex and invasive dosing procedure adds to the demand for efficient medical management. In light of the COVID-19 pandemic the value of drug delivery technologies in enabling a flexible care setting is broadly recognized. In such a setting, patients and their caregivers can choose the place of drug administration based on individual preferences and capabilities. This includes not only dosing in the clinic but also supervised at-home dosing and self-administration for eligible patients.
Formulation and Device Lifecycle Management of Biotherapeutics: A Guidance for Researchers and Drug Developers covers the various aspects of improving drug delivery of biological medicines with the ultimate goal to reduce dosing complexity associated with parenteral administration and, thus, enhance patient experience and drug administration-related healthcare capacity. The target audience are multidisciplinary researchers and drug developers in the pharmaceutical industry, biotech companies, and academia involved in formulation and device development. This includes pharmacology and medical experts in charge of generating nonclinical and clinical data to support approval of novel dosing regimens, and drug delivery scientists and engineers responsible for technical particulars of product optimizations. Moreover, professionals in market access and commercial functions are expected to benefit from the discussions about the impact of patient and healthcare provider needs and country-specific reimbursement models on realizing a truly convenient and cost and resource efficient drug delivery solution.
Summarizes formulation and device lifecycle management activities that enable customer-centric and sustainable drug delivery for biotherapeutics Describes the pharmacokinetic-based clinical development pathway for subcutaneous dosing alternatives to established intravenous formulations for monoclonal antibodies Details established clinical development pathways supporting the approval of automated subcutaneous injection devices and proposes novel concepts Discusses how to realize home- and self-administration of biotherapeutics in cancer care Highlights aspects of multidisciplinary formulation and device lifecycle management that can be leveraged across different disease areas and introduces a decision architecture on when and how drug developers should embark into related development activities348 kr
Skickas inom 5-8 vardagar
180 kr
Skickas inom 5-8 vardagar
428 kr
Skickas inom 5-8 vardagar
324 kr
Skickas inom 5-8 vardagar
331 kr
Skickas inom 5-8 vardagar
345 kr
Skickas inom 5-8 vardagar
166 kr
Skickas inom 5-8 vardagar
180 kr
Skickas inom 5-8 vardagar
372 kr
Skickas inom 5-8 vardagar
235 kr
Skickas inom 5-8 vardagar
2 201 kr
Skickas inom 10-15 vardagar
658 kr
Skickas inom 10-15 vardagar
296 kr
Skickas inom 7-10 vardagar
Herder Yearbook / Herder Jahrbuch
Volume 17 (2024)
1 272 kr
Skickas inom 5-8 vardagar
242 kr
Skickas inom 3-6 vardagar
605 kr
Skickas inom 5-8 vardagar
310 kr
Skickas inom 5-8 vardagar
307 kr
Skickas inom 5-8 vardagar
600 kr
Skickas inom 5-8 vardagar
297 kr
Skickas inom 3-6 vardagar
753 kr
Skickas inom 3-6 vardagar
429 kr
Skickas inom 3-6 vardagar
161 kr
Skickas inom 10-15 vardagar
554 kr
Skickas inom 3-6 vardagar
547 kr
Skickas inom 3-6 vardagar
575 kr
Skickas inom 3-6 vardagar
479 kr
Skickas inom 3-6 vardagar
738 kr
Skickas inom 5-8 vardagar
729 kr
Skickas inom 5-8 vardagar